Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.81% | $1.05B | €464.34B | 67.81% | 76 Outperform | |
| Roche Holding AG | 1.92% | $716.55M | CHF279.83B | 41.58% | 73 Outperform | |
| AstraZeneca | 1.84% | $686.59M | £210.86B | 19.89% | 80 Outperform | |
| HSBC Holdings | 1.79% | $668.80M | £220.77B | 51.99% | 80 Outperform | |
| Novartis AG | 1.75% | $654.73M | CHF218.15B | 19.92% | 80 Outperform | |
| Nestlé SA | 1.66% | $621.53M | CHF185.72B | 12.00% | 71 Outperform | |
| SAP SE | 1.65% | $618.24M | €194.20B | -37.58% | 66 Neutral | |
| Shell (UK) | 1.41% | $527.78M | £158.23B | 4.31% | 73 Outperform | |
| Siemens | 1.36% | $508.98M | €199.98B | 24.44% | 74 Outperform | |
| LVMH Moet Hennessy Louis Vuitton | 1.27% | $475.82M | €271.86B | -21.98% | 78 Outperform |